Immunogenicity of the 9-valent human papillomavirus vaccine: Post hoc analysis from five phase 3 studies.
Giuliano AR, Palefsky JM, Goldstone SE, Bornstein J, De Coster I, Guevara AM, Mogensen O, Schilling A, Van Damme P, Vandermeulen C, Ellison MC; Thomas Group; Kaplan S, Lin J, Bonawitz R, Luxembourg A.
Giuliano AR, et al. Among authors: kaplan s.
Hum Vaccin Immunother. 2025 Dec;21(1):2425146. doi: 10.1080/21645515.2024.2425146. Epub 2025 Jan 22.
Hum Vaccin Immunother. 2025.
PMID: 39840832
Free article.
Clinical Trial.